Search Within

Advanced Practice Providers

  1. "Sean Devlin"
Formats
  1. Meeting Abstract (37)
  2. Journal Article (29)
  3. Research Letter (2)
Groups
  1. Biostatistics Service (68)
  2. Center for Hematologic Malignancies (68)
  3. Department of Medicine (68)
  4. Epidemiology and Biostatistics (68)
  5. Hematologic Malignancies, Division of (68)
  6. Bone Marrow Transplant (60)

More Groups

People
  1. Sean Devlin (68)
  2. Sergio Giralt (49)
  3. Miguel-Angel Perales (47)
  4. Gunjan Shah (39)
  5. Michael Scordo (29)
  6. Molly Maloy (28)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (7)
  4. 2022 (8)
  5. 2021 (8)
  6. 2020 (9)

More Years

Publications
  1. Blood (24)
  2. Biology of Blood and Marrow Transplantation (11)
  3. Bone Marrow Transplantation (6)
  4. Transplantation and Cellular Therapy (5)
  5. Blood Advances (4)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. Elsevier Inc. (17)
  3. Nature Publishing Group (9)
  4. American Society of Clinical Oncology (2)
  5. Massachusetts Medical Society (2)
  6. Taylor & Francis Group (2)

More Publishers

Results (68)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A simple geriatric vulnerability index for older patients undergoing allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Jakubowski, A. A.; Shahrokni, A.; Dahi, P. B.; Perales, M. A.; Tamari, R.; Shaffer, B. C.; Sauter, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Homebound autologous hematopoietic cell transplantation for plasma cell disorders in an urban setting is safe for patients and preferred by patients and caregivers
    Meeting Abstract

    Landau, H. J.; Shah, G. L.; Reeds, M.; Hilden, P.; Andrejko, M.; Applebaum, A.; Batalha, J.; Cazeau, N.; Chung, D. J.; Cortes, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Impact of pre-transplant rituximab on efficacy of revaccination of lymphoma patients after autologous hematopoietic stem cell transplantation
    Meeting Abstract

    Preston, E. V.; Palazzo, M. A.; Seier, K.; Devlin, S. M.; Giralt, S.; Scordo, M.; Dahi, P. B.; Matasar, M. J.; Moskowitz, C. H.; Sauter, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Autologous CD19-Targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Journal Article

    Geyer, M. B.; Rivière, I.; Sénéchal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Halton, E.; Lamanna, N.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL
    Journal Article

    Sauter, C. S.; Matasar, M. J.; Schoder, H.; Devlin, S. M.; Drullinsky, P.; Gerecitano, J.; Kumar, A.; Noy, A.; Palomba, M. L.; Portlock, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Journal Article

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Maloy, M.; Kenny, S.; Hassoun, H.; Korde, N. S.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Rituximab use, immune reconstitution, and vaccination after ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Preston, E. V.; Malard, F.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; Smith, K.; Maslak, P.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of re-immunization with inactivated vaccines in multiple myeloma patients on lenalidomide maintenance following autologous hematopoietic stem cell transplantation (auto HCT)
    Meeting Abstract

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save